Ligand validation:2IBY

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2IBY_MES_A_5001	3%	7%	0.289	0.642	2.34	2.5	1	7	2	0	100%	0.9167
2IB9_MES_A_5001	29%	7%	0.206	0.865	2.25	2.48	1	7	0	0	100%	0.7917
2IB7_MES_A_5001	20%	8%	0.229	0.831	2.22	2.44	1	7	1	0	100%	0.7917
2IB8_MES_A_5001	17%	7%	0.231	0.811	2.23	2.55	1	7	0	0	100%	0.7917
2IBW_MES_A_5001	14%	6%	0.287	0.84	2.44	2.58	1	4	3	0	100%	0.7917
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	23%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	21%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	62%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1
4BRG_MES_B_1399	99%	15%	0.061	0.989	1.76	1.99	4	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.